Screener
Edwards Lifesciences EW Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding | — | — |
| Common stock, $1.00 par value, 1,050.0 shares authorized, 660.0 and 658.7 shares issued, and 577.0 and 580.7 shares outstanding, respectively | 660.0 | 658.7 |
| Additional paid-in capital | 2,781.5 | 2,768.4 |
| Retained earnings | 14,621.2 | 14,240.5 |
| Accumulated other comprehensive loss (Note 13) | (221.3) | (238.3) |
| Treasury stock, at cost, 83.0 and 78.0 shares, respectively | (7,513.9) | (7,091.7) |
| Total Edwards Lifesciences Corporation stockholders' equity | 10,327.5 | 10,337.6 |
| Total liabilities and equity | $13,321.2 | $13,697.2 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Edwards Lifesciences's treasury stock, shares (in shares)?
- Edwards Lifesciences (EW) reported treasury stock, shares (in shares) of 83M in Q1 2026.
- How has Edwards Lifesciences's treasury stock, shares (in shares) changed year-over-year?
- Edwards Lifesciences's treasury stock, shares (in shares) increased by 19.1% year-over-year, from 69.7M to 83M.
- What is the long-term trend for Edwards Lifesciences's treasury stock, shares (in shares)?
- Over 4 years (2021 to 2025), Edwards Lifesciences's treasury stock, shares (in shares) has grown at a 44.5% compound annual growth rate (CAGR), from 17.9M to 78M.
Ask your AI about Edwards Lifesciences's treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude